To confirm that, we examined the status of NF-κB activation in 6 pairs of glioblastoma tumour and normal samples and five general glioma cell lines, and the results suggested that their expression is frequently upregulated in glioblastoma (Fig. 1a, b). The gene discussed is NFKB1; the disease is central nervous system cancer.